FDA Inspection 1252554 — University of Chicago Medicine - Blood Bank

University of Chicago Medicine - Blood Bank — FEI 1472309

The FDA completed an inspection of University of Chicago Medicine - Blood Bank on October 18, 2024 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 18, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)